Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Rajputana Bio.
Quarter-by-quarter operating performance
Financials of Rajputana Bio.
Annual income statement trend
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales + | 10 | 17 | 23 | 53 | 67 | 122 |
| Expenses + | 10 | 16 | 20 | 46 | 58 | 107 |
| Operating Profit | -1 | 1 | 4 | 8 | 9 | 15 |
| OPM % | -7% | 7% | 15% | 14% | 13% | 12% |
| Other Income + | 0 | 0 | 0 | 0 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 0 | 1 | 1 |
| Profit before tax | -2 | 0 | 2 | 6 | 8 | 13 |
| Tax % | -26% | 30% | 26% | 26% | 21% | 22% |
| Net Profit + | -1 | 0 | 2 | 5 | 6 | 11 |
| EPS in Rs | -572.00 | 80.00 | 3.66 | 8.88 | 8.42 | 12.88 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Rajputana Bio.
Capital structure and asset base
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.03 | 0.03 | 5 | 5 | 7 | 7 |
| Reserves | -2 | -1 | -0 | 9 | 34 | 43 |
| Borrowings + | 9 | 11 | 9 | 19 | 14 | 28 |
| Other Liabilities + | 1 | 1 | 2 | 9 | 6 | 13 |
| Total Liabilities | 9 | 11 | 15 | 42 | 60 | 91 |
| Fixed Assets + | 4 | 4 | 4 | 7 | 6 | 9 |
| CWIP | 0 | 0 | 0 | 0 | 1 | 8 |
| Investments | 0 | 0 | 0 | 0 | 0 | 1 |
| Other Assets + | 4 | 7 | 11 | 36 | 54 | 73 |
| Total Assets | 9 | 11 | 15 | 42 | 60 | 91 |
Financials of Rajputana Bio.
Operating, investing and financing cash movement
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 1 | -1 | -1 | -5 | -15 | -3 |
| Cash from Investing Activity + | -2 | -0 | 1 | -3 | -2 | -9 |
| Cash from Financing Activity + | 1 | 3 | 1 | 11 | 15 | 12 |
| Net Cash Flow | 0 | 2 | 1 | 3 | -2 | 0 |
| Free Cash Flow | 1 | -1 | -1 | -6 | -17 | -15 |
| CFO/OP | -96% | -41% | -33% | -59% | -147% | -6% |
Financials of Rajputana Bio.
Working capital efficiency and return ratios
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 29 | 28 | 48 | 87 | 82 | 47 |
| Inventory Days | 29 | 60 | 108 | 108 | 132 | 132 |
| Days Payable | 14 | 16 | 27 | 29 | 15 | 21 |
| Cash Conversion Cycle | 44 | 72 | 130 | 166 | 199 | 158 |
| Working Capital Days | -292 | -130 | 45 | 70 | 186 | 102 |
| ROCE % | 13% | 27% | 31% | 21% | 22% |